Alice Wolfromm

424 citations
10 papers · 274 · h-index 6

Impact in

  • Hematology top 10%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Acute Myeloid Leukemia Research 4
    • Multiple Myeloma Research and Treatments 2
    • Chronic Myeloid Leukemia Treatments 1
    • Chronic Lymphocytic Leukemia Research 4
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 2

Alice Wolfromm

9 papers receiving 274 citations

Peers

Alice Wolfromm
Comparison fields: 5 of 68
  • Hematology 92
  • Genetics 68
  • Nephrology 37
  • Pharmacology 53
  • Infectious Diseases 56
Replace Chisato Sato with:
Chisato Sato Japan
Tal Schiller Israel
Ignacio García-Valladares United States
Nagao Shinagawa Japan
Nishant Verma India
Jie Peng China
Yuko Kanbayashi Japan
S. Flechner United States
Stephan Lorenz Germany
T J Schroeder United States
Alice Wolfromm relative to Chisato Sato Japan Chisato Sato's profile →
Citations per field
00.5×
Chisato Sato · 1×
Citations per year

Countries citing papers authored by Alice Wolfromm

Since Specialization
Citations

This map shows the geographic impact of Alice Wolfromm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice Wolfromm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice Wolfromm more than expected).

Fields of papers citing papers by Alice Wolfromm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alice Wolfromm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice Wolfromm. The network helps show where Alice Wolfromm may publish in the future.

Co-authors

The 25 scholars most cited alongside Alice Wolfromm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alice Wolfromm Line = papers co-authored together Alice Wolfromm links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1 201796
2 201380
3 201337
4 201424
5 201515
6 201114
7 20175
8 20112
9 20101
10 20200

About Alice Wolfromm

Alice Wolfromm is a scholar working on Hematology, Genetics, Infectious Diseases, Molecular Biology and Surgery, having authored 10 papers that have together received 274 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Multiple Myeloma Research and Treatments (2 papers), Poisoning and overdose treatments (1 paper), Antimicrobial Resistance in Staphylococcus (1 paper), Histone Deacetylase Inhibitors Research (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Hematology (92 citations), Genetics (68 citations), Nephrology (37 citations), Pharmacology (53 citations) and Infectious Diseases (56 citations). Alice Wolfromm has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Pierre Fenaux, Raphaël Itzykson, Éric Rondeau, Lionel Adès, Laurent Mesnard, Rami S. Komrokji, Jaroslaw P. Maciejewski, Mikkael A. Sekeres, Ramón V. Tiu and F. Dreyfus. Their work appears in journals such as Blood, British Journal of Haematology, Cell Cycle, Kidney International and Journal of the American Society of Nephrology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact